Identification of signalling pathways influenced by E-cadherin

Detalhes bibliográficos
Autor(a) principal: Henriques, Lara João Cardoso
Data de Publicação: 2007
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10216/22116
Resumo: E-cadherin is a calcium-dependent glycoprotein that mediates cell-cell adhesion and is important in differentiation, cell growth and maintenance of cell polarity. The involvement of E-cadherin in tumour development has been extensively demonstrated, with many human carcinomas exhibiting reduced E-cadherin expression. In gastric cancer, the protein is abnormally expressed in more than half of the cases of the sporadic diffuse subset. Furthermore, germline loss-of-function mutations in the CDH1 gene were shown to represent the genetic cause of approximately 1/3 of HDGC cases. During tumourigenesis, loss of E-cadherin expression and/or function can lead to increased cell motility, cell-cell detachment and, ultimately, to invasion. Moreover, recent evidences point for the possible involvement of the protein in modulating intracellular signalling and thus have a contribution during initial stages of tumour development. To investigate the hypothesis that E-cadherin modulates intracellular signalling and to understand to what extent two germline mutations localized in different domains of E-cadherin and identified in HDGC cases maintain normal function, we transduced Wild-type, extracellular-mutated and intracellular-mutated forms of E-cadherin to a cell that does not express the protein. We analyzed expression and putative activity changes to key proteins of four signalling pathways implicated in cell survival, proliferation, cell-matrix adhesion and invasion. We demonstrate that expression of Wild-type E-cadherin inhibits PI3K and RTKs signalling, a capacity most likely dependent on the extracellular domain. We show that MMPs activity and FAK-dependent intracellular signalling is decreased with the expression of normal E-cadherin. Finally, and despite similar outcomes in terms of invasion, motility and overall malignancy, missense mutations localized in different domains of E-cadherin render opposite effects in intracellular signalling. Results obtained for the extracellular mutation were comparable to the lack of protein situation. In contrast, cells with the intracellular mutation behaved more similarly to Wild-type cells. Taken together, our results show that E-cadherin modulates intracellular signalling. These novel properties may contribute to tumour development by influencing cell proliferation and survival, cell adhesion, motility and invasion. Although these are preliminary findings, the possibility that causes for malignancy associated with mutations localized at the extracellular domain of E-cadherin may have been identified is very promising, in particular for gastric neoplasias treatment.
id RCAP_126c7818dbc579412f1cbc46bb770dfb
oai_identifier_str oai:repositorio-aberto.up.pt:10216/22116
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Identification of signalling pathways influenced by E-cadherinMedicina e Oncologia MolecularPortoE-cadherin is a calcium-dependent glycoprotein that mediates cell-cell adhesion and is important in differentiation, cell growth and maintenance of cell polarity. The involvement of E-cadherin in tumour development has been extensively demonstrated, with many human carcinomas exhibiting reduced E-cadherin expression. In gastric cancer, the protein is abnormally expressed in more than half of the cases of the sporadic diffuse subset. Furthermore, germline loss-of-function mutations in the CDH1 gene were shown to represent the genetic cause of approximately 1/3 of HDGC cases. During tumourigenesis, loss of E-cadherin expression and/or function can lead to increased cell motility, cell-cell detachment and, ultimately, to invasion. Moreover, recent evidences point for the possible involvement of the protein in modulating intracellular signalling and thus have a contribution during initial stages of tumour development. To investigate the hypothesis that E-cadherin modulates intracellular signalling and to understand to what extent two germline mutations localized in different domains of E-cadherin and identified in HDGC cases maintain normal function, we transduced Wild-type, extracellular-mutated and intracellular-mutated forms of E-cadherin to a cell that does not express the protein. We analyzed expression and putative activity changes to key proteins of four signalling pathways implicated in cell survival, proliferation, cell-matrix adhesion and invasion. We demonstrate that expression of Wild-type E-cadherin inhibits PI3K and RTKs signalling, a capacity most likely dependent on the extracellular domain. We show that MMPs activity and FAK-dependent intracellular signalling is decreased with the expression of normal E-cadherin. Finally, and despite similar outcomes in terms of invasion, motility and overall malignancy, missense mutations localized in different domains of E-cadherin render opposite effects in intracellular signalling. Results obtained for the extracellular mutation were comparable to the lack of protein situation. In contrast, cells with the intracellular mutation behaved more similarly to Wild-type cells. Taken together, our results show that E-cadherin modulates intracellular signalling. These novel properties may contribute to tumour development by influencing cell proliferation and survival, cell adhesion, motility and invasion. Although these are preliminary findings, the possibility that causes for malignancy associated with mutations localized at the extracellular domain of E-cadherin may have been identified is very promising, in particular for gastric neoplasias treatment.Faculdade de Medicina da Universidade do PortoFMUP20072011-02-07T00:00:00Z2011-02-07info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/10216/22116porHenriques, Lara João Cardosoinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T12:34:51Zoai:repositorio-aberto.up.pt:10216/22116Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T23:22:54.520994Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Identification of signalling pathways influenced by E-cadherin
title Identification of signalling pathways influenced by E-cadherin
spellingShingle Identification of signalling pathways influenced by E-cadherin
Henriques, Lara João Cardoso
Medicina e Oncologia Molecular
Porto
title_short Identification of signalling pathways influenced by E-cadherin
title_full Identification of signalling pathways influenced by E-cadherin
title_fullStr Identification of signalling pathways influenced by E-cadherin
title_full_unstemmed Identification of signalling pathways influenced by E-cadherin
title_sort Identification of signalling pathways influenced by E-cadherin
author Henriques, Lara João Cardoso
author_facet Henriques, Lara João Cardoso
author_role author
dc.contributor.author.fl_str_mv Henriques, Lara João Cardoso
dc.subject.por.fl_str_mv Medicina e Oncologia Molecular
Porto
topic Medicina e Oncologia Molecular
Porto
description E-cadherin is a calcium-dependent glycoprotein that mediates cell-cell adhesion and is important in differentiation, cell growth and maintenance of cell polarity. The involvement of E-cadherin in tumour development has been extensively demonstrated, with many human carcinomas exhibiting reduced E-cadherin expression. In gastric cancer, the protein is abnormally expressed in more than half of the cases of the sporadic diffuse subset. Furthermore, germline loss-of-function mutations in the CDH1 gene were shown to represent the genetic cause of approximately 1/3 of HDGC cases. During tumourigenesis, loss of E-cadherin expression and/or function can lead to increased cell motility, cell-cell detachment and, ultimately, to invasion. Moreover, recent evidences point for the possible involvement of the protein in modulating intracellular signalling and thus have a contribution during initial stages of tumour development. To investigate the hypothesis that E-cadherin modulates intracellular signalling and to understand to what extent two germline mutations localized in different domains of E-cadherin and identified in HDGC cases maintain normal function, we transduced Wild-type, extracellular-mutated and intracellular-mutated forms of E-cadherin to a cell that does not express the protein. We analyzed expression and putative activity changes to key proteins of four signalling pathways implicated in cell survival, proliferation, cell-matrix adhesion and invasion. We demonstrate that expression of Wild-type E-cadherin inhibits PI3K and RTKs signalling, a capacity most likely dependent on the extracellular domain. We show that MMPs activity and FAK-dependent intracellular signalling is decreased with the expression of normal E-cadherin. Finally, and despite similar outcomes in terms of invasion, motility and overall malignancy, missense mutations localized in different domains of E-cadherin render opposite effects in intracellular signalling. Results obtained for the extracellular mutation were comparable to the lack of protein situation. In contrast, cells with the intracellular mutation behaved more similarly to Wild-type cells. Taken together, our results show that E-cadherin modulates intracellular signalling. These novel properties may contribute to tumour development by influencing cell proliferation and survival, cell adhesion, motility and invasion. Although these are preliminary findings, the possibility that causes for malignancy associated with mutations localized at the extracellular domain of E-cadherin may have been identified is very promising, in particular for gastric neoplasias treatment.
publishDate 2007
dc.date.none.fl_str_mv 2007
2011-02-07T00:00:00Z
2011-02-07
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10216/22116
url http://hdl.handle.net/10216/22116
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Faculdade de Medicina da Universidade do Porto
FMUP
publisher.none.fl_str_mv Faculdade de Medicina da Universidade do Porto
FMUP
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799135530552655872